This inventor holds 2 USPTO granted patents. Top assignee: Dna Vec Research Inc.. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Tsuyoshi Tokusumi: Innovator in Gene Therapy
Introduction
Tsuyoshi Tokusumi is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of gene therapy through his innovative work with paramyxovirus vectors. With a total of 2 patents, his research focuses on developing viral vectors that can effectively transfer foreign genes.
Latest Patents
Tokusumi's latest patents include groundbreaking advancements in the use of envelope gene-deficient paramyxovirus vectors. His work demonstrates the successful recovery of F gene-deficient virus virions using an F gene-deficient Sendai virus genomic cDNA. Furthermore, he has constructed infectious viral particles by utilizing F-expressing cells as helper cells. His research also includes the recovery of F gene and HN gene-deficient virus virions, leading to the production of infectious viral particles with the help of F- and HN-expressing cells. Additionally, he has developed techniques for constructing deficient viruses that contribute to the advancement of vectors of Paramyxoviridae, which are essential for gene therapy applications.
Career Highlights
Tokusumi is currently associated with Dna Vec Research Inc., where he continues to push the boundaries of gene therapy research. His innovative approaches have positioned him as a key figure in the development of safe and efficient gene transfer methods.
Collaborations
Some of his notable coworkers include Akihiro Iida and Mamoru Hasegawa, who have collaborated with him on various projects related to gene therapy and viral vector development.
Conclusion
Tsuyoshi Tokusumi's contributions to the field of gene therapy through his innovative patents and research are paving the way for future advancements in medical science. His work exemplifies the potential of viral vectors in enhancing gene transfer efficiency and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile